291. Hirschsprung disease, entire colon type Clinical trials / Disease details
Clinical trials : 12 / Drugs : 24 - (DrugBank : 15) / Drug target gene : 0 - Drug target pathway : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00630838 (ClinicalTrials.gov) | September 2006 | 28/2/2008 | Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC) | Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC) | Hirschsprung Disease | Drug: VSL#3;Drug: Placebo | University of Michigan | NULL | Completed | 1 Month | 12 Months | All | 62 | Phase 2 | United States |